Trials / Not Yet Recruiting
Not Yet RecruitingNCT06819501
Hyperbaric Oxygen Therapy for Peripheral Neuropathy Due to Paclitaxel Analogs
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 226 (estimated)
- Sponsor
- Guangdong Provincial People's Hospital · Academic / Other
- Sex
- Female
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this study was to explore the safety and efficacy of hyperbaric oxygen in the treatment of peripheral neuropathy due to paclitaxel analogues
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | hyperbaric oxygenation treatment | Administration of 100% oxygen at a pressure of 2.0ATA once daily for 60-90 minutes for a total of 30-40 times. |
| BEHAVIORAL | routine care | Administration of pressurised ice gloves 30 minutes before, during, and 30 minutes after administering paclitaxel chemotherapy drugs. |
Timeline
- Start date
- 2025-02-05
- Primary completion
- 2026-09-01
- Completion
- 2026-09-01
- First posted
- 2025-02-11
- Last updated
- 2025-02-11
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06819501. Inclusion in this directory is not an endorsement.